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A putative endogalactanase gene classified into glycoside hydrolase family 53 was revealed from the genome
sequence of Bifidobacterium longum strain NCC2705 (Schell et al., Proc. Natl. Acad. Sci. USA 99:14422–14427,
2002). Since only a few endo-acting enzymes from bifidobacteria have been described, we have cloned this gene
and characterized the enzyme in detail. The deduced amino acid sequence suggested that this enzyme was
located extracellularly and anchored to the cell membrane. galA was cloned without the transmembrane
domain into the pBluescript SK() vector and expressed in Escherichia coli. The enzyme was purified from the
cell extract by anion-exchange and size exclusion chromatography. The purified enzyme had a native molecular
mass of 329 kDa, and the subunits had a molecular mass of 94 kDa, which indicated that the enzyme occurred
as a tetramer. The optimal pH of endogalactanase activity was 5.0, and the optimal temperature was 37°C,
using azurine-cross-linked galactan (AZCL-galactan) as a substrate. The Km and Vmax for AZCL-galactan were
1.62 mM and 99 U/mg, respectively. The enzyme was able to liberate galactotrisaccharides from (134)ga-
lactans and (134)galactooligosaccharides, probably by a processive mechanism, moving toward the reducing
end of the galactan chain after an initial midchain cleavage. GalA’s mode of action was found to be different
from that of an endogalactanase from Aspergillus aculeatus. The enzyme seemed to be able to cleave (133)
linkages. Arabinosyl side chains in, for example, potato galactan hindered GalA.
Bifidobacteria play an important role in carbohydrate fer-
mentation in the colon. They contain a large number of car-
bohydrate-modifying enzymes. Since the genome sequence of
Bifidobacterium longum recently became available (36), more
information about Bifidobacterium glycolytic enzymes has been
uncovered. The genome reveals that approximately 5% of all
annotated genes are involved in the modification of carbohy-
drates.
Several studies on in vitro fermentations of (134)-linked
(arabino)galactans with different bifidobacteria show that
mainly B. longum strains were able to grow on these arabinoga-
lactans (9, 11). This is consistent with the genome sequence of
B. longum because it reveals the presence of many different
putative enzymes potentially able to degrade arabinogalactans.
Most of these enzymes are probably located intracellularly,
and their sequence suggests that they can degrade the side
chains of galactans (arabinofuranosidases and arabinosidases)
or galactooligosaccharides (-galactosidases) (36). Interest-
ingly, the genome sequence also suggests that B. longum con-
tains an endogalactanase (annotated as YvfO and further re-
ferred to as GalA in this study), which is predicted to be
extracellular. This is rather exceptional, because only few
endo-acting enzymes have been described in bifidobacteria so
far (2, 24).
Most endogalactanases described to date are able to de-
grade the (134)-linked galactosyl backbone of type I arabi-
nogalactans (6, 20, 21, 28, 39). Neither the substrate specificity
of GalA is clear nor if it truly acts with an endomechanism. It
is possible that this enzyme is an essential link in galactan
utilization, together with -galactosidases, arabinofuranosi-
dases, and transporters of galactooligosaccharides. To get
more insight into galactan utilization by B. longum, we have
cloned the galA gene, characterized this enzyme in detail, and
compared its mode of action with an endogalactanase from
Aspergillus aculeatus.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Bifidobacterium longum strain
NCC490 was kindly provided by the Nestle´ Research Centre (Lausanne, Swit-
zerland). The strain was grown anaerobically using MRS medium, pH 6.0 (Bec-
ton Dickinson, Franklin Lakes, New Jersey) supplemented with 0.5 g/liter cys-
teine at 37°C. DNA cloning was performed using the Escherichia coli strain
XL1-Blue MRF (Promega, Madison, Wisconsin). The E. coli strain was grown
in Luria-Bertani (LB) broth or solidified LB medium (15 g agar/l) supplemented
with 100 g/ml ampicillin, when appropriate.
The E. coli cells containing the galA gene were grown in LB broth or solidified
LB medium, supplemented with 100 g/ml ampicillin and 1 mM isopropyl -D-
thiogalactopyranoside (IPTG).
Chemicals, substrates, and enzymes. Chemicals were purchased from Sigma
(St. Louis, MO), unless stated otherwise. Potato arabinogalactan was obtained as
described by van de Vis (40). Azurine-cross-linked galactan (AZCL-galactan)
was purchased from Megazyme (Bray, Ireland). Endogalactanase from Aspergil-
lus aculeatus was purified as described by van de Vis et al. (41). Arabinofurano-
sidase from Aspergillus niger was purchased from Megazyme. Restriction en-
zymes and other enzymes used for DNA manipulation were obtained from MBI
Fermentas (St. Leon Rot, Germany) and were used according to the instructions
of the manufacturer. The mixture of transgalactooligosaccharides (TOS) was
kindly provided by Borculo Domo Ingredients (Zwolle, The Netherlands) and
was fractionated as described by Van Laere et al. (43). [-D-Galp-(134)]m-D-
Galp and [-D-Galp-(134)]n--D-Galp-(133)-D-Galp oligosaccharides, with m
 1 to 3 and n  1 or 2, were obtained as described by Hinz et al. (16).
Cloning of the endogalactanase gene. Genomic DNA of B. longum was iso-
lated using a modified Marmur procedure as described by Johnson (18). A PCR
was carried out on the genomic DNA with Easy A polymerase (Stratagene, La
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FIG. 1. ClustalW comparison of the amino acid sequence of endogalactanase from Bifidobacterium longum (GalA) and endogalactanases from
Aspergillus aculeatus (accession no. ASNGAL1A), Bacillus licheniformis (AAO31370), Corynascus heterothallicus (AAN99814), and Humicola
insolens (AAN99815). Amino acid identity is indicated by vertical black shading, and the catalytic residues E192 and E297 are indicated by diamonds.
The secondary structure elements are indicated by “H” for helices and “S” for strands. The signal peptide of GalA is underlined, whereas its
transmembrane domain is boxed. The residues involved in calcium binding are indicated by squares. The Trp residues representing subsites 2,
3, and 4 are shaded in grey.
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Jolla, California), using two primers for amplification of the galA gene without
the transmembrane domain (XbaI restriction sites were introduced at the be-
ginning and at the end of the gene for cloning purposes). Primers used were (with
the XbaI site underlined) 257F (5-CCCCCCCTCTAGACAAAGGAGAAAA
AGCATGCG), and 257R (5-CCCCCCCTCTAGATCAGCTACCGGTATTG
CTCAG). The forthcoming DNA fragments were ligated into a pGEM T-easy
vector (Promega) and transformed into E. coli XL1-Blue MRF cells. The cells
were grown for 16 h at 37°C on solid S-Gal (3,4-cyclohexenoesculetin--D-
galactopyranoside)/LB agar plates (Sigma), supplemented with 100 g/ml ampi-
cillin. Colonies containing a PCR fragment were identified as white colonies.
Plasmid DNA was prepared by following the QIAGEN plasmid purification
method (QIAGEN, Hilden, Germany). The galA genes were cut out from the
plasmids with XbaI and purified and cloned into an XbaI-digested pBluescript
vector (Stratagene). This vector was transformed into E. coli XL1-Blue MRF
cells.
Isolation and characterization of endogalactanase. E. coli cells containing the
galA gene were grown overnight at 37°C (1 liter) and harvested by centrifugation
(15 min, 8,000  g, 4°C). The supernatant was used for activity measurement,
and the cells were suspended in 90 ml 50 mM sodium acetate buffer, pH 5, and
disrupted by sonic treatment (10 min; amplitude, 30%; duty cycle, 0.3 s on and
0.7 s off; Digital Sonifier; Branson, Danbury, CT) on ice. Subsequently, the
suspension was centrifuged (15 min, 8,000  g, 4°C), the cell extract was col-
lected, the pellet was suspended in 40 ml 50 mM sodium acetate buffer (pH 5),
and a second sonic treatment was performed. This step was repeated twice. The
cell extracts were pooled and applied onto a Q-Sepharose (Amersham, Little
Chalfont, United Kingdom) anion-exchange column, using a BioPilot pump
system (Amersham). Elution was done with a linear gradient of 0 to 0.5 M NaCl
in 50 mM sodium acetate, pH 5, at a flow rate of 57 cm/h. Fractions with the
highest endogalactanase activity were pooled and further purified on a Superdex
200 PG (Amersham) size exclusion column. Elution was performed with 0.15 M
NaCl in 20 mM potassium phosphate buffer, pH 6.0, at a flow rate of 76 cm/h.
Fractions with the highest endogalactanase activity were pooled and concen-
trated with anion-exchange chromatography under the same conditions as de-
scribed above.
Protein concentration was determined by the method of Bradford (5) using
bovine serum albumin as a standard. Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) was carried out on the Pharmacia Phastsystem
according to the instructions of the supplier (Amersham). Coomassie brilliant
blue staining was used for the detection of proteins on PhastGel 10 to15%
gradient gels (Amersham). The native molecular mass was estimated by size
exclusion chromatography using the Akta Purifier equipped with a Superdex 200
PG column (Amersham), as described above. The column was calibrated with
thyroglobulin (669 kDa), ferritin (440 kDa), catalase (232 kDa), aldolase (158
kDa), bovine serum albumin (67 kDa), ovalbumin (43 kDa), chymotrypsinogen
A (25 kDa), and RNase A (13.7 kDa).
Enzyme assays. Endogalactanase activity was measured by determining the
hydrolysis of AZCL-galactan (according to instructions of the supplier) at 37°C
after 15 min of incubation. The reaction mixture (250 l) consisted of 1.85 g of
enzyme, 16 mM potassium phosphate buffer (pH 6.0), and 2.5 mg AZCL-
galactan. The reaction was stopped by adding an equal volume of 0.5 M glycine-
NaOH buffer (pH 9.0) containing 2 mM EDTA. After centrifugation (15 min,
10,000  g), the absorbance of the supernatant was measured at 595 nm (A595).
The absorbance at 595 nm is a measure for the activity of the enzyme. In a
parallel experiment, the A595 of a number of representative incubations with
AZCL-galactan was related to the amount of reducing end groups formed. From
this, a conversion factor was calculated, which enabled the conversion of the A595
readings to enzyme activity units. One unit of activity was defined as 1 mol of
reducing sugars liberated per min under the specified conditions. This assay was
also used to measure the enzyme’s optimum temperature and pH and for kinetic
experiments. The optimum temperature was determined between 4 and 70°C.
For determination of the optimum pH, McIlvain buffers (0.1 M citric acid, 0.2 M
disodium phosphate) in the range of pH 2.6 to 7.6 were used. For kinetic
experiments, the AZCL-galactan concentration was varied in the range of 0.08 to
16.0 mg/ml.
The mode of action of GalA was determined by high-performance anion-
exchange chromatography (HPAEC) and high-performance size exclusion chro-
matography (HPSEC). The incubations were performed in triplicate with 5
mg/ml potato galactan in 5 mM sodium acetate buffer, pH 5.0, and 3.3 U/ml
enzyme at 37°C for different time intervals. The incubations were stopped by
heating the incubation mixtures for 10 min at 100°C. After centrifugation (10
FIG. 2. Overlay of the catalytic residues, Trp residues involved in
substrate binding, and loop 7/8 region of the 3D structures of GalA
(lighter shade) and endogalactanase from Bacillus licheniformis
(darker shade). The catalytic residues are indicated in red, the Trp
residues (representing subsites2,3, and4) in pink, loop 7 in blue,
and loop 8 in green.
TABLE 1. Physicochemical properties of endogalactanase from
Bifidobacterium longum
Parameter (units) Endogalactanasevalue
Km (mg/ml)
a 1.62
Vmax (U/mg)
a 99
Deduced molecular mass (Da) 91,288
Molecular mass (kDa) (SDS-PAGE) 94
Native molecular mass (kDa) 329
Proposed molecular structure Tetramer
Optimum pH 5.0
Optimum temperature (°C) 37
a AZCL-galactan as substrate.
TABLE 2. Sugar composition of potato arabinogalactan and tetramer fraction obtained after partial degradation of galactan
as described by Hinz et al. (16)
Fraction
Monosaccharidea composition (mol%) Carbohydrate
contentb (%)
Gal/Ara
ratioFuc Rha Ara Gal Glc GalA
Potato galactan 1.2  0.2 6.5  0.3 13.9  0.2 65.8  0.3 1.2  0.0 11.3  0.3 76.0  2.6 4.7
Tetramer 5.9  0.1 94.1  0.1 97.6  3.6 16
a Fuc, fucose; Rha, rhamnose; Ara, arabinose; Gal, galactose; Glc, glucose; GalA, galacturonic acid.
b Expressed as wt/vol.
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min, 10,000  g), the supernatant was analyzed by HPAEC, HPSEC, and the
Nelson-Somogyi method.
The substrate specificity was also measured by HPAEC in triplicate. The
incubations were performed with 1 mg/ml substrate in 45 mM sodium acetate
buffer, pH 5.0, and 0.067 U/ml enzyme at 37°C for 30 and 120 min. The incu-
bations were stopped and analyzed as described above.
The influence of arabinosyl side chains on the hydrolytic activity of GalA was
measured by HPAEC. The incubations were performed with 5 mg/ml potato
galactan in 5 mM sodium acetate buffer, pH 5.0, and 13.6 U/ml arabinofurano-
sidase at 30°C for 24 h. The incubations were stopped by heating the incubation
mixtures for 10 min at 100°C. After cooling to 37°C, 3.3 U/ml GalA was added
and the samples were incubated at 37°C for 48 h. The incubations were stopped
and analyzed as described above. All reactions were carried out in triplicate.
Analytical methods. HPAEC was performed using a Thermo-Quest high-
performance liquid chromatography system equipped with a Dionex CarboPac
PA-1 (4 mm ID by 250 mm) column in combination with a CarboPac PA guard
column (3 mm ID by 25 mm) and a Dionex ED40 PAD detector (Dionex Co.,
Sunnyvale). A flow rate of 1 ml/min was used with the following gradient of
sodium acetate in 0.1 M NaOH: 0 to 40 min, 0 to 400 mM; 40 to 41 min, 400 to
1,000 mM. Each elution was followed by a washing step for 5 min with 1,000 mM
sodium acetate in 0.1 M NaOH and an equilibration step of 15 min 0.1 M NaOH.
HPSEC was performed on three TSKgel columns (7.8 mm ID by 30 cm per
column) in series (G4000 PWXL, G3000 PWXL, G2500 PWXL; Tosohaas,
Stuttgart, Germany), in combination with a PWX-guard column (Tosohaas).
Elution took place at 30°C with 0.2 M sodium nitrate at 0.8 ml/min. The eluate
was monitored by refractive index detection using a Shodex RI-72 detector
(Kawasaki, Japan). Calibration was performed using dextrans (Amersham).
For matrix-assisted laser desorption ionization–time of flight mass spectrom-
etry (MALDI-TOF MS), an Ultraflex workstation (Bruker Daltronics GmbH,
Germany) was used. The mass spectrometer was calibrated with a mixture of
maltodextrins. The samples were mixed with a matrix solution (1 l each). The
matrix solution was prepared by dissolving 9 mg of 2,5-dihydroxybenzoic acid and
3 mg 1-hydroxyisoquinoline in a 1-ml mixture of acetonitrile and water (3:7). The
prepared sample and matrix solutions were put on a gold plate and dried under
a stream of warm air.
The concentration of reducing sugars was determined according to the Nelson-
Somogyi method (29), using galactose as standard.
DNA sequencing and sequence analysis. An automated model 373 DNA
sequencer (Applied Biosystems) was used to determine the nucleotide sequence
of the gene. The DNA sequence data are available at the GenBank nucleotide
databases under the accession number NC_004307. The BLAST2 program (1;
available at http://www.ncbi.nlm.nih.gov/) was used for detecting sequence ho-
mologies. The SWISS-MODEL version 36.0003 program (14, 31, 37) (available
from http://www.expasy.org/swissmod/SWISS-MODEL.html) was used for ho-
mology modeling.
RESULTS
Characterization of galA from Bifidobacterium longum. The
galA gene consisted of an open reading frame of 2.6 kb. Ap-
proximately 10 nucleotides upstream of the start codon, a
putative ribosomal binding site, AGGAG, was found. Analysis
of the open reading frame predicted a molecular mass of
91,366 Da and an isoelectric point of 4.19 of the translation
product.
GalA was classified in the glycoside hydrolase family 53
(GH53) according to the method of Henrissat et al. (15) at
http://afmb.cnrs-mrs.fr/CAZY/index.html. A ClustalW com-
parison of four endogalactanases of which the three-dimen-
sional (3D) structure is known (Aspergillus aculeatus GenBank
accession no. ASNGAL1A [7, 35], Bacillus licheniformis
strain AAO31370 [4, 34], Corynascus heterothallicus strain
AAN99814 [23], Humicola insolens strain AAN99815 [19, 23])
and GalA from B. longum was performed (Fig. 1). Based on
the 3D structures, the catalytic residues of GalA were sug-
gested to be E192 and E297. As expected, these 2 amino acid
residues are conserved in all GH53 members (Fig. 1). The
alignment showed that the enzyme was twice as large as the
other endogalactanases. Analysis of the domain structure, us-
ing Prodom (8) (http://protein.toulouse.inra.fr/prodom/2003.1
/html/form.php), showed that the catalytic domain is located
between amino acids 55 and 429; the domain structure of the
C-terminal extension was not further specified by the program.
Signal peptide and transmembrane domain prediction using
SignalP (30) (http://www.cbs.dtu.dk/services/SignalP/), PSORT
(27) (http://psort.nibb.ac.jp/), and SOSUI (17) (http://sosui
.proteome.bio.tuat.ac.jp/sosuiframe0.html) showed that GalA
had a signal peptide and a transmembrane domain (Fig. 1).
FIG. 3. HPSEC profiles of potato arabiogalactan degradation after 0, 1, and 24 h of incubation by GalA (A) and endogalactanase from A.
aculeatus (B). Symbols: }, polymeric potato arabinogalactan; , degradation products of potato arabinogalactan with an average molecular mass
of 11 kDa; ✶, low-molecular-mass oligosaccharides (approximately 370 Da); ✚, acetate buffer; ■, higher-molecular-mass oligosaccharides
(approximately 500 to 2,400 Da). RI, refractive index.
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These results suggested that GalA is an extracellular enzyme
which is anchored to the cell membrane. The galA gene was
cloned without the transmembrane domain.
A putative 3D structure of GalA was obtained by homology
modeling, using the structure of the endogalactanase from B.
licheniformis (4, 34) as a template. Of the four enzymes with a
known 3D structure, the one from B. licheniformis had the
highest identity (54%) with GalA. Amino acids 39 to 440 were
incorporated in the model. For the B. licheniformis endogalac-
tanase, it has been reported that loops 7 and 8 are longer than
those in fungal endogalactanses (34). These loops contained
residues involved in calcium binding. Further, the B. licheni-
formis endogalactanase showed the presence of three Trp res-
idues (two of which were part of loop 8) representing subsites
2,3, and4 in the substrate-binding groove of the enzyme.
The presence of subsites 3 and 4 was consistent with the
enzyme mainly liberating galactotetrasaccharides from galac-
tan. The putative 3D structure of GalA also showed the pres-
ence of the extended loops 7 and 8, the residues involved in
calcium binding, and the two Trp residues in loop 8 (Fig. 1).
Interestingly, an overlay of the structures of GalA and the B.
licheniformis endogalactanase (Fig. 2) showed a difference in
orientation of these aromatic amino acid residues between the
two enzymes, particularly of the Trp (Trp405) residue of sub-
site 4. It seems as if the subsite 4 Trp of GalA points away
from the substrate-binding groove, which might indicate that
this enzyme releases shorter products.
Purification and physicochemical properties. The total en-
dogalactanase activity of the 1-liter cell culture was 271 U in
the cell extract and 209 U in the cell culture supernatant. The
cell extract was used for the purification of GalA by anion-
exchange chromatography and size exclusion chromatography
because it contained the most activity. The enzyme was pure
after these chromatographic steps, as judged by SDS-PAGE
and Coomassie brilliant blue staining. The physicochemical
properties of GalA are given in Table 1. The native molecular
mass of the enzyme was determined by size exclusion chroma-
tography, whereas the molecular mass of the subunits was
determined by SDS-PAGE with Coomassie brilliant blue stain-
ing. GalA had a native molecular mass of 329 kDa, and the
subunits (SDS-PAGE) showed a molecular mass of 94 kDa,
which corresponds well with the molecular mass calculated
from the deduced amino acid sequence (91 kDa). This indi-
cated that GalA occurs as a tetramer.
Mode of action. The mode of action of GalA toward arabi-
nogalactan was determined by the degradation of potato ga-
lactan. The monosaccharide composition of potato arabinoga-
lactan is shown in Table 2, suggesting that this arabinogalactan
preparation also contained some remnants of pectic material.
The Gal/Ara ratio was 4.7 (16). The galactan degradation was
followed by HPSEC (Fig. 3) and HPAEC (Fig. 4). A shift in
the molecular mass of galactan occurred after 1 h of incuba-
tion, together with the appearance of a peak in the low-mo-
lecular-mass region (Fig. 3A). After prolonged incubation, the
peak in the low-molecular-mass region increased and the ga-
lactan was reduced further in molecular size. The mode of
action of GalA was compared with an endogalactanase from A.
aculeatus which is also a GH53 family member. Initially, this
latter enzyme had a similar shift in molecular mass of the
polymeric galactan after 1 h (Fig. 3B), but prolonged incuba-
tion showed the formation of oligomers larger than the ones
observed after incubation with GalA. HPSEC analysis revealed
that 20 and 22% of the starting material was degraded after
1 h, whereas at the end point degradation (data not shown), 67
and 60% was degraded by GalA and the endogalactanase from
A. aculeatus, respectively. HPAEC was used to determine the
nature of the oligomers. The HPAEC profiles of the digests
obtained with endogalactanase degradation (Fig. 4A) showed
that GalA had a preference to liberate galactotrisaccharides.
After prolonged incubation, galactose and galactobiose were
also formed. Besides these products, some minor oligosaccha-
rides were released which probably correspond to galactobiose
with an arabinosyl residue as determined by MALDI-TOF MS
(Fig. 4C). The degradation pattern of galactan by endogalac-
tanase from A. aculeatus appeared to follow a different pattern
(Fig. 4B). After an incubation time of 16 h, a range of oligo-
saccharides with a different degree of polymerization was
FIG. 4. HPAEC profiles of potato arabinogalactan degradation af-
ter 0, 7, 16, and 120 h of incubation by GalA (A) and endogalactanase
from A. aculeatus (B) and a MALDI-TOF MS profile of the potato
arabinogalactan digest after 7 h of incubation with endogalactanase
from B. longum (C). Symbols: }, galactose; ■, galactodisaccharide
[-D-Galp(134)-D-Gal]; Œ, galactotrisaccharide [-D-Galp(134)-
D-Galp(134)-D-Galp]; F, galactotetrasaccharides [-D-Galp(134)-
D-Galp(134)-D-Galp(134)-D-Galp]; ✱, galactooligosaccharides
with a degree of polymerization of 5; GG, galactobiose; GGA, ar-
abinosyl-galactobiose; GGG, galactotriose. PAD, pulsed amperomet-
ric detection.
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formed, of which the galactotetraose peak was the most pre-
dominant one. Exhaustive incubation showed degradation of
all oligomers to galactose and galactobiose.
The degradation of potato galactan with GalA was moni-
tored in time (Fig. 5). The results from this experiment showed
clearly that the enzyme initially liberated galactotrisaccharides
from the polymeric galactan. After an incubation of 24 h, the
enzyme started to degrade the trisaccharide to galactose and
galactobiose. A very small amount of galactotetrasaccharide
was found during the first 20 h of incubation.
To compare the mode of action of GalA and A. aculeatus
endogalactanase, the molecular weight of the galactan was
plotted versus the amount of reducing sugars formed upon
incubation for different periods of time (Fig. 6). An exo-acting
enzyme will form a large amount of reducing sugars with a slow
collapse of the molecular weight. On the other hand, an endo-
acting enzyme will show a much lower formation of reducing
sugars, with a large decrease in molecular weight. The curves
clearly showed that the mode of action of GalA was different
from that of A. aculeatus. This latter enzyme was characterized
as an endo-acting enzyme (41). GalA showed behavior toward
the potato galactan, which was clearly different from an endo-
acting enzyme.
As mentioned before, GalA has a putative calcium-binding
FIG. 5. The formation of galactotrisaccharide (Œ), galactodisaccharide (), galactose (}), and galactotetrasaccharide (E) during the degra-
dation of potato arabinogalactan by GalA over time. The amount of products formed is relative to the HPAEC peak area of the maximal amount
of galactose formed. The standard deviation is indicated by error bars.
FIG. 6. The amount of reducing sugars formed by the action of GalA (E) and endogalactanase from A. aculeatus (‚) versus the reduction of
molecular weight of the polymeric galactan. The standard deviation is indicated by error bars.
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site. To examine whether GalA required calcium ions for ac-
tivity, it was incubated with potato galactan in the presence of
1 mM EDTA or 1 mM CaCl2. In both cases, GalA released a
similar amount of galactotriose as without these additions,
indicating that calcium is not necessary for the enzyme’s activ-
ity. It is possible that calcium plays a role in the stability of the
enzyme, but this was not further investigated.
Substrate specificity. As described previously, potato galac-
tan contained a small amount of (133) linkages in the back-
bone (16). However, in none of the performed experiments
with GalA galactotriose with a (133) linkage was this found.
This might suggest that the (133) linkages were degraded by
the enzyme. Therefore, a galactooligosaccharide mixture con-
taining -D-Galp-(134)--D-Galp-(134)--D-Galp-(133)--
D-Galp and -D-Galp-(134)--D-Galp-(134)--D-Galp-(134)-
-D-Galp was incubated with GalA. Table 2 shows the
monosaccharide composition of this tetramer fraction. Only
the trisaccharide Galp-(134)--D-Galp-(134)--D-Galp was
found when both galactotetrasaccharides were completely de-
graded (Fig. 7A). From this result, it was concluded that GalA
is able to cleave the (133) linkage in the tetramer. Since a
small amount of -D-Galp-(134)--D-Galp-(134)--D-Galp-
(133)--D-Galp is still available after an incubation of 120
min, it is suggested that the (134) linkage may be degraded
faster than the (133) linkage. GalA is not capable to degrade
type II galactan from gum arabic (data not shown), in which
every galactosyl residue of the backbone is substituted with
arabinosyl-galactosyl side chains (41). It is not clear whether
the enzyme is hindered by the larger amount of side chains or
whether it cannot degrade contiguous (133)-linked galacto-
syl residues. The tetramer fraction was also treated with the
endogalactanase from A. aculeatus (Fig. 7B). This endogalac-
tanase liberated mainly galactobiose and galactose from both
the galactotetrasaccharides. This enzyme was less active to-
ward the (133) linkage, since more disaccharide Galp-
(133)--D-Galp accumulated in contrast with the incubation
with GalA.
TOS is a mixture of different types of -galactooligosaccha-
rides derived after the transglycosylation of lactose with a -ga-
lactosidase and can be used as a prebiotic. TOS was incubated
with GalA. The enzyme liberated galactotrisaccharides from
the substrate which were mainly pentasaccharides, resulting in
an increased concentration of di- and trisaccharides (Fig. 8).
However, the enzyme was unable to hydrolyze all the different
types of oligosaccharides in the mixture of TOS, since some
peaks in the chromatogram remained unaltered.
Potato galactan contains arabinosyl side chains in a Gal/Ara
ratio of 4.7 (Table 2). In Fig. 4A and C, the presence of
trisaccharides containing arabinosyl residues was already indi-
cated. The influence of the arabinosyl residues on the activity
of GalA was examined by preincubation of potato galactan
with an arabinofuranosidase from A. niger. This enzyme was
able to remove the arabinosyl residues from the galactan. After
the pretreatment, the galactan was subjected to degradation
FIG. 7. HPAEC diagrams of the degradation of the tetramer frac-
tion (purified after partial digestion of potato galactan with endoga-
lactanase from A. niger [16]) with GalA (A) and endogalactanase from
A. aculeatus (B). G, galactose; G4G, -D-Galp(134)-D-Galp; G3G,
-D-Galp(133)-D-Galp; (G4)2G, -D-Galp(134)-D-Galp(134)-
D-Galp; G4G3G, -D-Galp(134)-D-Galp(133)-D-Galp; (G4)3G,
-D-Galp(134)-D-Galp(134)-D-Galp(134)-D-Galp; (G4)2G3G,
-D-Galp(134)-D-Galp(134)--D-Galp(133)-D-Galp. PAD, pulsed
amperometric detection.
FIG. 8. HPAEC profiles of TOS degradation with GalA. The iden-
tity of several peaks in the TOS HPAEC profile are unknown, but
oligosaccharides present include [-D-Galp-(134)]n--D-Galp-(134)-
-D-Glcp, [-D-Galp-(134)]n--D-Galp-(136)--D-Glcp, 	-D-Glcp-
(171)--D-Galp, -D-Galp-(132)-	-D-Glcp-(171)--D-Galp, [-D-
Galp-(134)]n-	-D-Glcp-(171)--D-Galp, -D-Galp-(134)-	-D-Glcp-
(17 1)--D-Galp-[(134)--D-Galp]n, with n 1 to 4 (12). , galactose
and/or glucose; ✱, galactosyl dimers; }, galactosyl trimers; ✚, galac-
tosyl tetramers; ✖, galactosyl pentamers; Œ, galactosyl hexamers. PAD,
pulsed amperometric detection.
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with GalA. The amount of trimer liberated from the substrate
increased by 13% compared to the degradation of nonpre-
treated potato galactan when a pretreatment was performed
(data not shown), which suggested that the enzyme is hindered
by the arabinosyl side chains.
DISCUSSION
Several fermentation studies showed that B. longum was able
to use polymeric arabinogalactan as a substrate (9, 11, 42). This
paper provides the first description of a polysaccharide-de-
grading enzyme from B. longum, further supporting the view
that galactans can be fermented by bifidobacteria. This en-
zyme, GalA, was able to degrade galactooligosaccharides with
both (134) and (133) linkages; it was hindered by arabi-
nosyl side chains of the type I arabinogalactan, and it was not
active toward type II galactans. Interestingly, GalA liberated
galactotrisaccharides from type I arabinogalactan. This is con-
sistent with the GalA structure modeled in Fig. 2, which sug-
gested that two Trp residues (subsites 2 and 3), and not
three as with Bacillus licheniformis endogalactanase, are lining
the substrate-binding groove. It thus seems that Trp405 of
GalA is not positioned correctly for substrate binding, as a
result of which galactotriose, and not galactotetraose, is the
main product of the enzyme.
Several galactanases are found in bacteria (6, 20, 21, 39) and
Aspergillus spp. (7, 10, 22, 41). Most endogalactanases de-
scribed in the literature initially produce a range of oligosac-
charides with different degrees of polymerization, and after
prolonged incubations, only mono- and disaccharides remain.
In this paper, we showed that GalA acts with a different mode
of action. The HPSEC profiles of the galactan degradation
showed that GalA initially seemed to act with an endomecha-
nism (Fig. 3). However, the results presented in Fig. 6 sug-
gested an exomechanism. Combining these results, we propose
that GalA acts with a processive mechanism, i.e., after an
initial midchain (or endo-) cleavage, the enzyme remains at-
tached to the galactan and liberates galactotrisaccharides in an
exofashion (3, 32). Because the enzyme liberated trisaccha-
rides from the galactotetrasaccharides and the (133) linkage
was at the reducing end of the oligosaccharides, it was con-
cluded that GalA is moving toward the reducing end of a
galactan chain.
The processive mode of action of GalA might be related to
its C-terminal extension. Most endogalactanases have a mo-
lecular mass of 30 to 50 kDa, whereas GalA was approximately
twice as large (Fig. 1). A separate BLAST search with this
C-terminal part revealed homology to bacterial endogalacta-
nases (Enterococcus faecium strain ZP_00286096, Thermotoga
maritima strain NP_229006, Streptomyces avermitilis strain
NP_822499) and dextranase (Paenibacillus sp. strain AAQ91294).
Because homology was found only with the noncatalytic parts
of the mentioned enzymes, it is still unclear what the function
of this C-terminal extension is. It might be involved in protein-
protein interactions leading to the formation of the tetramer,
since the GH53 galactanases with known 3D structure seem to
occur as monomers (23, 34, 35). Another explanation might be
that the extension is folded over the catalytic cleft in such a way
that it is more difficult for the galactan to leave the catalytic site
(and therewith enforcing processivity). For cellobiohydrolase
Cel7D from Trichoderma reesei (44), it has been found that its
processivity is related to a protein loop, which covers the
groove with the catalytic residues, giving the enzyme a tunnel-
like appearance. It should be noted that this loop is only 32
FIG. 9. Schematic representation of the putative degradation of galactans and internalization of galactooligosaccharides in Bifidobacterium
longum (A) and Bifidobacterium bifidum (B). GalA, endogalactanase GalA from B. longum; BIF3, -galactosidase BIF3 from B. bifidum; -Gals,
different -galactosidases; OT, oligosaccharide transporter; HT, hexose transporter.
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amino acids long, whereas the C-terminal extension of GalA is
approximately 430 amino acids. Truncation of the galA gene
can help to unravel the nature of this C-terminal part.
As mentioned before, GalA is probably anchored at the
extracellular side of the cell membrane. There, the processive
mechanism of the enzyme may ensure that a galactan chain
does not escape to the environment and remains attached to
the enzyme until it is completely degraded. In this way, the
enzyme can secure substrate for itself, when the galactotrisac-
charides formed are directly transported into the bacterial cell
(Fig. 9A), where they can be further degraded by -galactosi-
dases (33, 38). The B. longum genome sequence did not reveal
any extracellular -galactosidase. Furthermore, the genome se-
quence showed the presence of several putative oligosaccharide
transporters (NP_695366, NP_695367, NP_696791, NP_696790,
NP_696339, NP_696339, NP_695267), which await further
characterization. A transport mechanism for galactooligosac-
charides has been suggested for Bifidobacterium lactis (13),
since this bacterium had seemed to grow better on galacto-
trisaccharides and galactotetrasaccharides than on mono- and
disaccharides. It is unclear whether arabinosylated galactooli-
gosaccharides (formed upon arabinogalactan degradation) can
be taken up by B. longum.
The presence of oligosaccharide transporters is not neces-
sarily common in bifidobacteria. It is known that Bifidobacte-
rium bifidum contains a -galactosidase (BIF3) which is ex-
pected to be located extracellularly (25) and contains a
putative galactose-binding domain. Possibly, this binding do-
main mediates attachment of the enzyme to galactosyl residues
of the constituent polysaccharides of the Bifidobacterium cell
wall (26). In this case, galactooligosaccharides might be de-
graded extracellularly to monomers, which can be internalized
through the more common hexose transporters, and no special
oligosaccharide transporter will be needed (Fig. 9B). From the
considerations given above, it is evident that bifidobacteria can
have different toolboxes to utilize galactans or galactooligosac-
charides. It will be necessary to conduct more research to
further unravel the mechanisms by which bifidobacteria de-
grade and take up carbohydrates.
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